Genpact Limited (G) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
G Revenue Growth
Revenue Breakdown (FY 2025)
G's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
G Revenue Analysis (2014–2025)
As of May 8, 2026, Genpact Limited (G) generated trailing twelve-month (TTM) revenue of $5.16 billion, reflecting solid growth of +6.7% year-over-year. The most recent quarter (Q1 2026) recorded $1.30 billion in revenue, down 1.8% sequentially.
Looking at the longer-term picture, G's 5-year compound annual growth rate (CAGR) stands at +6.5%, indicating steady revenue expansion. The company achieved its highest annual revenue of $5.08 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows G's business is primarily driven by Consumer And Healthcare (100%). With over half of revenue concentrated in Consumer And Healthcare, the company maintains significant focus in this area while developing other growth vectors.
When compared to Technology sector peers including EXLS (+13.4% YoY), EPAM (+14.2% YoY), and CTSH (+6.5% YoY), G has underperformed the peer group in terms of revenue growth. Compare G vs EXLS →
G Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GCurrent | $5.2B | +6.7% | +6.5% | 15.0% | |
 EXLS | $2.1B | +13.4% | +16.8% | 15.0% | |
 EPAM | $5.5B | +14.2% | +15.5% | 9.6% | |
 CTSH | $21.1B | +6.5% | +4.9% | 16.7% | |
 WIT | $901.3B | +1.5% | +6.5% | 17.0% | |
 ACN | $69.7B | +7.3% | +9.5% | 14.7% |
G Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.08B | +6.6% | $1.81B | 35.6% | $760.0M | 15.0% |
| 2024 | $4.77B | +6.5% | $1.69B | 35.5% | $702.1M | 14.7% |
| 2023 | $4.48B | +2.4% | $1.57B | 35.1% | $630.9M | 14.1% |
| 2022 | $4.37B | +8.7% | $1.54B | 35.1% | $502.2M | 11.5% |
| 2021 | $4.02B | +8.4% | $1.43B | 35.6% | $509.0M | 12.7% |
| 2020 | $3.71B | +5.4% | $1.29B | 34.8% | $438.7M | 11.8% |
| 2019 | $3.52B | +17.3% | $1.23B | 34.8% | $429.4M | 12.2% |
| 2018 | $3.00B | +9.6% | $1.08B | 36.0% | $348.2M | 11.6% |
| 2017 | $2.74B | +6.5% | $1.06B | 38.6% | $331.3M | 12.1% |
| 2016 | $2.57B | +4.5% | $1.02B | 39.5% | $341.2M | 13.3% |
See G's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs G Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare G vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonG — Frequently Asked Questions
Quick answers to the most common questions about buying G stock.
Is G's revenue growth accelerating or slowing?
G maintains +6.7% revenue growth, in line with its 5-year CAGR of +6.5%. TTM revenue stands at $5.2B. Growth rate remains consistent with historical average.
What is G's long-term revenue growth rate?
Genpact Limited's 5-year revenue CAGR of +6.5% reflects the sustained expansion pattern. Current YoY growth of +6.7% is near this long-term average.
How is G's revenue distributed by segment?
G reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.